Croda International Plc (LON:CRDA)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 4.56B +33.2% |
| Revenue (ttm) | 1.72B +3.4% |
| Net Income | 79.50M -43.2% |
| EPS | 0.57 -43.1% |
| Shares Out | 139.92M |
| PE Ratio | 57.23 |
| Forward PE | 19.26 |
| Dividend | 1.11 (3.38%) |
| Ex-Dividend Date | Aug 27, 2026 |
| Volume | n/a |
| Open | 3,287.00 |
| Previous Close | 3,285.00 |
| Day's Range | 3,250.00 - 3,302.00 |
| 52-Week Range | 2,437.00 - 3,352.00 |
| Beta | 0.92 |
| Analysts | Buy |
| Price Target | 3,600.00 (+10.5%) |
| Earnings Date | Jul 28, 2026 |
About Croda International
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, crop protection, and seed coating systems and enhancement technologies to improve germination. In addition, the company offers industrial specialties, including phase change materials; surfa... [Read more]
Financial Performance
In 2025, Croda International's revenue was 1.70 billion, an increase of 4.38% compared to the previous year's 1.63 billion. Earnings were 62.00 million, a decrease of -60.88%.
Financial StatementsAnalyst Summary
According to 14 analysts, the average rating for CRDA stock is "Buy." The 12-month stock price target is 3,600p, which is an increase of 10.50% from the latest price.
News
Earnings tonic boosts FTSE 100 as oil falls back
Well-received earnings from Unilever, Croda and GSK spurred gains on the blue-chip FTSE 100.
Half Year 2026 Croda International PLC Earnings Presentation Transcript
Half Year 2026 Croda International PLC Earnings Presentation Transcript
Croda International H1 Earnings Call Highlights
Croda International LON: CRDA said its first-half results met expectations as growth accelerated in the second quarter, supported by Consumer Care and a strong performance in Beauty Actives. The compa...
Croda International Earnings Call Transcript: H1 2026
First half results were in line with expectations, with profits outpacing sales and strong growth in Consumer Care, especially Beauty Actives. Transformation initiatives and innovation are driving margin expansion, and full-year guidance is reaffirmed.
Croda International Quarterly report: H1 2026
Croda International has published its H1 2026 quarterly earnings report on July 28, 2026.
Croda International Slides: H1 2026
Croda International has posted slides in relation to its H1 2026 quarterly earnings report, which was published on July 28, 2026.
Croda International Dividend Yield Hits 3.7% as Stock Trades 70% Below Its Peak
The Croda International dividend yield has climbed to close to 3.7%, more than double its ten-year average of 1.5%, at a moment when the speciality chemicals company is trading roughly 70% below its 2...
Croda International Earnings Call Transcript: Q1 2026
Q1 2026 sales rose 1% at constant currency, with Consumer Care up and Life Sciences down. No material impact from Middle East conflict; full-year outlook unchanged, supported by strong order book, ongoing transformation, and price increases to offset inflation.
Croda International Earnings release: Q1 2026
Croda International released its Q1 2026 earnings on April 22, 2026, summarizing the period's financial results.
Croda International Earnings Call Transcript: H2 2025
Sales rose 7% in constant currency with strong growth in patented ingredients and Consumer Care. Transformation initiatives are driving margin recovery, with a target of over 20% operating margin by 2028 and free cash flow conversion above 12%.
Croda International Annual report: H2 2025
Croda International has published its H2 2025 annual report on February 24, 2026.
Croda International Annual report: H2 2025
Croda International has published its H2 2025 annual report on February 24, 2026.
Croda International Slides: H2 2025
Croda International has posted slides in relation to its H2 2025 quarterly earnings report, which was published on February 24, 2026.
Croda International Earnings Call Transcript: Q3 2025
Sales rose 6.5% in constant currency, led by innovation in Beauty Actives and F&F, with Crop recovering. Full-year guidance is unchanged amid market uncertainty, with cost savings and margin recovery on track. Q4 is expected to be seasonally lower.
Croda International Earnings release: Q3 2025
Croda International released its Q3 2025 earnings on October 16, 2025, summarizing the period's financial results.
Croda International shares jump after Standard Industries unit discloses stake
Shares of Croda International Plc surged 4.7% on Thursday, marking the British chemicals supplier's strongest daily gain since April 23. The rally came after a filing revealed that Standard Latitude M...
Croda International Earnings Call Transcript: H1 2025
First half results showed 7% sales growth and 12% profit growth, driven by strong volumes and cost savings, despite price pressures and macro uncertainty. The transformation program targets £100 million in annualized savings by 2027, with full-year guidance unchanged.
Croda International Quarterly report: H1 2025
Croda International has published its H1 2025 quarterly earnings report on July 29, 2025.
Croda International Slides: H1 2025
Croda International has posted slides in relation to its H1 2025 quarterly earnings report, which was published on July 29, 2025.
Croda International Transcript: Trading Update
Sales grew 8% (9% at constant currency) in Q1, led by strong volumes across all businesses and improved asset utilization. Tariff surcharges are being applied, with no evidence of pre-buying, and full-year guidance is unchanged amid a stable margin and ongoing cost savings.
Croda International Earnings release: Trading Update
Croda International released its earnings on April 23, 2025, summarizing the period's financial results.
Croda International Earnings Call Transcript: H2 2024
Sales declined 4% but profits met guidance due to cost control, with strong free cash flow and a modest dividend increase. Consumer Care and Life Sciences are set for growth in 2025, supported by operational efficiencies and a focus on local/regional customers.
Croda International Annual report: H2 2024
Croda International has published its H2 2024 annual report on February 25, 2025.
Croda International Annual report: H2 2024
Croda International has published its H2 2024 annual report on February 25, 2025.
Croda International Slides: H2 2024
Croda International has posted slides in relation to its H2 2024 quarterly earnings report, which was published on February 25, 2025.